3rd Annual CKD3, March 2-4 2021
For the 3rd year, the chronic Kidney Disease Drug Development Summit (CKD3) is putting the hottest topics in CKD drug development under the spotlight. Across 3 days of content, the world-class faculty will address questons including: what is the drug development opportunity beyond current standards of care including SGLT-2 and GLP-1, how is pharma harnessing the power of AI and what kidney organoids are providing innovation to target identification? CKD3 is the definitive, intimately focused forum promoting cross stakeholder discussion and networking to accelerate the next line of CKD drugs.
A selection of speakers: Maria Gomez LUDC, Matthias Kretzler University of Michigan, Jeremy Duffield Vertex Pharmaceuticals, Jyothis George Novo Nordisk, Uptal Patel Gilead, Aliza Thompson FDA.